Treatment with interferon gamma (IFN-gamma), an immune signaling molecule, helped to protect against damage in a cellular model of…
Articles by Marisa Wexler, MS
In a deal worth more than $7 billion, Biogen is acquiring Reata Pharmaceuticals, the developers of…
The U.S. Food and Drug Administration (FDA) has greenlighted a request by Larimar Therapeutics to test a 50 mg…
Measuring abnormalities in the neurological circuits the brain uses to make sense of sound could be a useful way to…
Fredrich’s ataxia (FA) impairs the regulation of hundreds of genes in muscle cells, resulting in reduced activity in those…
A new assay to measure levels of the frataxin protein in blood could be used to assess the effectiveness of…
Motion-capture suits can be combined with machine learning to predict how Friedreich’s ataxia (FA) will progress, a new proof-of-concept…
Abnormalities in the light-sensing cells of the eyes are detectable in carriers of Friedreich’s ataxia (FA), but do not…
Objective measures of eye movement abnormalities are associated with measures of disease severity in Friedriech’s ataxia (FA) and other…
Among people with Friedreich’s ataxia, thinner layers of nerve cells at the retina — the light-sensing cells located at…